Cargando…

EE315 Economic Evaluation of Neutralising Monoclonal Antibodies for the Treatment of COVID-19 Positive People in the Community

Detalles Bibliográficos
Autores principales:	Metry, A, Rafia, R, Wailoo, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232817/ http://dx.doi.org/10.1016/j.jval.2022.04.560

Ejemplares similares

Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus
por: Berry, Jody D, et al.
Publicado: (2004)

A Cost-Effectiveness Analysis of Remdesivir for the Treatment of Hospitalized Patients With COVID-19 in England and Wales
por: Rafia, Rachid, et al.
Publicado: (2022)

Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking
por: Acquaye‐Seedah, Edith, et al.
Publicado: (2018)

Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation
por: Seow, Han Cong, et al.
Publicado: (2023)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Engineering, Expression in Transgenic Plants and Characterisation of E559, a Rabies Virus-Neutralising Monoclonal Antibody
por: van Dolleweerd, Craig J., et al.
Publicado: (2014)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY
por: Green, Amelia C A, et al.
Publicado: (2023)

Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
por: Moore, Catherine M., et al.
Publicado: (2021)

mAb CZP-315.D9: An Antirecombinant Cruzipain Monoclonal Antibody That Specifically Labels the Reservosomes of Trypanosoma cruzi Epimastigotes
por: Batista, Cassiano Martin, et al.
Publicado: (2014)

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
por: Kinsley, Rebecca, et al.
Publicado: (2020)

Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody
por: Quijada, Hector, et al.
Publicado: (2021)

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
por: Wang, Youchun
Publicado: (2021)

Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2
por: Davidson, Natalie, et al.
Publicado: (2021)

Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes
por: Smith, Teresa C., et al.
Publicado: (2023)

Economic evaluation of monoclonal antibody in the management of colorectal cancer in Malaysia
por: Natrah, MS, et al.
Publicado: (2012)

Insensitivity of Paediatric HIV-1 Subtype C Viruses to Broadly Neutralising Monoclonal Antibodies Raised against Subtype B
por: Gray, Elin Solomonovna, et al.
Publicado: (2006)

Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis
por: McConnell, David, et al.
Publicado: (2022)

Neutralising antibodies for Mayaro virus in Pantanal, Brazil
por: Pauvolid-Corrêa, Alex, et al.
Publicado: (2015)

Schmallenberg virus neutralising antibody responses in sheep
por: Jones, Scott, et al.
Publicado: (2019)

EE450 Treatments and Diagnostics for COVID-19: A Living Systematic Review of Economic Evaluations
por: Elvidge, J, et al.
Publicado: (2022)

EE7 Economic Evaluation of COVID-19 Vaccines: A Targeted Literature Review
por: Addae, A, et al.
Publicado: (2022)

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies
por: Wilhelm, Alexander, et al.
Publicado: (2022)

Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma
por: Sasson, S. C., et al.
Publicado: (2021)

Detection of transmissible gastroenteritis virus neutralising antibody in cats
por: Reynolds, D. J., et al.
Publicado: (1977)

Sindbis virus neutralising antibodies detected in Swedish horses
por: Björnström, Agnes, et al.
Publicado: (2021)

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application
por: Hargreaves, Alexander, et al.
Publicado: (2021)

Neutralising antibody titers and COVID outcomes in cancer patients
por: Lee, Matilda Xinwei, et al.
Publicado: (2023)

EE99 Economic Burden of COVID-19 in Mexico
por: Frias Gasga, AE, et al.
Publicado: (2022)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

Evasion of neutralising antibodies by omicron sublineage BA.2.75
por: Sheward, Daniel J, et al.
Publicado: (2022)

Neutralisation of uPA with a Monoclonal Antibody Reduces Plasmin Formation and Delays Skin Wound Healing in tPA-Deficient Mice
por: Jögi, Annika, et al.
Publicado: (2010)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Evaluation of a Virus Neutralisation Test for Detection of Rift Valley Fever Antibodies in Suid Sera
por: Lubisi, Baratang A., et al.
Publicado: (2019)

Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
por: Handisurya, A, et al.
Publicado: (2016)

Reviewers BJCVS 31.5
Publicado: (2016)

Health Tract No. 315: Presentiments
Publicado: (1868)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2b5nggig1d2656dhacporh1l9i